Article(id=1236369018882421430, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369013111050820, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1684425600000, acceptedDateStr=2023-05-19, onlineDate=1772702944727, onlineDateStr=2026-03-05, pubDate=1694707200000, pubDateStr=2023-09-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772702944727, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772702944727, creator=13701087609, updateTime=1772702944727, updator=13701087609, issue=Issue{id=1236369013111050820, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='17', pageStart='1697', pageEnd='1800', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772702943351, creator=13701087609, updateTime=1772703317941, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236370584322495028, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369013111050820, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236370584326689333, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236369013111050820, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=1707, endPage=1711, ext={EN=ArticleExt(id=1236369019171828425, articleId=1236369018882421430, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Brief analysis on the collaboration of drugs for rare diseases in China, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

The drug R&D of rare diseases in China is still in early stage. Collaborations have become a choice for many companies to enter that field. This article analyzes the collaboration deals involving Chinese companies from year 2011 to April 30th, 2022 on drugs with indication included in the first batch of rare disease list. It is found that as the country has put more emphasis on rare diseases, the number of transactions has increased significantly after the year of 2019. The deal model is mainly licensing deal, and transactions in rare disease indications with a big population is relatively concentrated. A group of biotechnology companies with rare diseases as their strategic focus have emerged. It is suggested to promote the legislation of rare diseases in China and more incentive policies concerning the research and development in rare diseases can be introduced in the future, so as to promote more Chinese companies to join in the research and development of innovative drugs in the rare diseases, and to further accelerate the development of local innovative drugs for rare diseases.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Ying-hui YU, Yun-feng LIAO, Bin ZHOU), CN=ArticleExt(id=1236369019444458196, articleId=1236369018882421430, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=我国罕见病药物合作情况简析, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

我国企业在罕见病药物研发领域尚处于起步阶段,合作成为很多企业进入罕见病领域的选择。本文对2011年至2022年4月30日我国企业涉及第一批罕见病目录适应证药物的合作情况进行分析,发现随着国家对罕见病重视程度的提升,2019年之后合作数量有显著提升,合作方式以许可引进为主,人群较多的罕见病合作数量较为集中,涌现出了一批以罕见病为战略领域的生物科技企业。建议推动罕见病立法,可以出台更多罕见病研发相关的政策鼓励和激励企业加入罕见病领域的创新药研发中,推动本土创新罕见病药物的发展。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
周斌,男,研究员,博士研究生导师,主要从事医药产业经济政策与医药政策法规研究。E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=rPlGShoz7JtNHegxtJGfNA==, magXml=z+CXOIqsqQ0LpEWFTt93Rg==, pdfUrl=null, pdf=TD+BCMhLf9c9gi2pWb3p4w==, pdfFileSize=3461260, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=dGlGDUjClpRiZTx0Xbvb6w==, mapNumber=null, authorCompany=null, fund=null, authors=

俞颖慧,女,博士研究生,主要从事社会管理药学研究。E-mail:

, authorsList=俞颖慧, 廖云凤, 周斌)}, authors=[Author(id=1236369020061020915, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=euge_013@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369020157489914, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020061020915, language=EN, stringName=Ying-hui YU, firstName=Ying-hui, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369020228793084, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020061020915, language=CN, stringName=俞颖慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国医药工业研究总院中国医药工业信息中心,上海 201203, bio={"content":"

俞颖慧,女,博士研究生,主要从事社会管理药学研究。E-mail:

"}, bioImg=null, bioContent=

俞颖慧,女,博士研究生,主要从事社会管理药学研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369019742253793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, xref=1, ext=[AuthorCompanyExt(id=1236369019763225315, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China), AuthorCompanyExt(id=1236369019792585446, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国医药工业研究总院中国医药工业信息中心,上海 201203)])]), Author(id=1236369020371399428, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369020488839941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020371399428, language=EN, stringName=Yun-feng LIAO, firstName=Yun-feng, middleName=null, lastName=LIAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Tasly Biopharmaceutical Company, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369020618863371, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020371399428, language=CN, stringName=廖云凤, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2天士力生物医药股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369019935191788, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, xref=2, ext=[AuthorCompanyExt(id=1236369019943580397, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019935191788, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Tasly Biopharmaceutical Company, Shanghai 201203, China), AuthorCompanyExt(id=1236369019956163311, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019935191788, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2天士力生物医药股份有限公司,上海 201203)])]), Author(id=1236369020719526675, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhoubin@sinopharm.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236369020820189978, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020719526675, language=EN, stringName=Bin ZHOU, firstName=Bin, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236369020916658977, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, authorId=1236369020719526675, language=CN, stringName=周斌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国医药工业研究总院中国医药工业信息中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236369019742253793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, xref=1, ext=[AuthorCompanyExt(id=1236369019763225315, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China), AuthorCompanyExt(id=1236369019792585446, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国医药工业研究总院中国医药工业信息中心,上海 201203)])])], keywords=[Keyword(id=1236369021034099498, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=EN, orderNo=1, keyword=rare disease drugs), Keyword(id=1236369021109596977, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=EN, orderNo=2, keyword=collaboration), Keyword(id=1236369021222843195, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=EN, orderNo=3, keyword=company), Keyword(id=1236369021331895109, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=CN, orderNo=1, keyword=罕见病药物), Keyword(id=1236369021474501451, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=CN, orderNo=2, keyword=合作), Keyword(id=1236369021587747666, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, language=CN, orderNo=3, keyword=企业)], refs=null, funds=null, companyList=[AuthorCompany(id=1236369019742253793, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, xref=1, ext=[AuthorCompanyExt(id=1236369019763225315, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China), AuthorCompanyExt(id=1236369019792585446, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019742253793, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国医药工业研究总院中国医药工业信息中心,上海 201203)]), AuthorCompany(id=1236369019935191788, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, xref=2, ext=[AuthorCompanyExt(id=1236369019943580397, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019935191788, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Tasly Biopharmaceutical Company, Shanghai 201203, China), AuthorCompanyExt(id=1236369019956163311, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236369018882421430, companyId=1236369019935191788, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2天士力生物医药股份有限公司,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I17/1707, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I17/1707, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I17/1707, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I17/1707, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
我国罕见病药物合作情况简析
收藏切换
PDF下载
俞颖慧 1 , 廖云凤 2 , 周斌 1
中国新药杂志 | 新药述评与论坛 2023,32(17): 1707-1711
收起
收藏切换
中国新药杂志 | 新药述评与论坛 2023, 32(17): 1707-1711
我国罕见病药物合作情况简析
全屏
俞颖慧1 , 廖云凤2, 周斌1
作者信息
  • 1中国医药工业研究总院中国医药工业信息中心,上海 201203
  • 2天士力生物医药股份有限公司,上海 201203
  • 俞颖慧,女,博士研究生,主要从事社会管理药学研究。E-mail:

通讯作者:

周斌,男,研究员,博士研究生导师,主要从事医药产业经济政策与医药政策法规研究。E-mail:
Brief analysis on the collaboration of drugs for rare diseases in China
Ying-hui YU1 , Yun-feng LIAO2, Bin ZHOU1
Affiliations
  • 1China State Institute of Pharmaceutical Industry China National Pharmaceutical Industry Information Center, Shanghai 201203, China
  • 2Tasly Biopharmaceutical Company, Shanghai 201203, China
出版时间: 2023-09-15
文章导航
收藏切换

我国企业在罕见病药物研发领域尚处于起步阶段,合作成为很多企业进入罕见病领域的选择。本文对2011年至2022年4月30日我国企业涉及第一批罕见病目录适应证药物的合作情况进行分析,发现随着国家对罕见病重视程度的提升,2019年之后合作数量有显著提升,合作方式以许可引进为主,人群较多的罕见病合作数量较为集中,涌现出了一批以罕见病为战略领域的生物科技企业。建议推动罕见病立法,可以出台更多罕见病研发相关的政策鼓励和激励企业加入罕见病领域的创新药研发中,推动本土创新罕见病药物的发展。

罕见病药物  /  合作  /  企业

The drug R&D of rare diseases in China is still in early stage. Collaborations have become a choice for many companies to enter that field. This article analyzes the collaboration deals involving Chinese companies from year 2011 to April 30th, 2022 on drugs with indication included in the first batch of rare disease list. It is found that as the country has put more emphasis on rare diseases, the number of transactions has increased significantly after the year of 2019. The deal model is mainly licensing deal, and transactions in rare disease indications with a big population is relatively concentrated. A group of biotechnology companies with rare diseases as their strategic focus have emerged. It is suggested to promote the legislation of rare diseases in China and more incentive policies concerning the research and development in rare diseases can be introduced in the future, so as to promote more Chinese companies to join in the research and development of innovative drugs in the rare diseases, and to further accelerate the development of local innovative drugs for rare diseases.

rare disease drugs  /  collaboration  /  company
俞颖慧, 廖云凤, 周斌. 我国罕见病药物合作情况简析. 中国新药杂志, 2023 , 32 (17) : 1707 -1711 .
Ying-hui YU, Yun-feng LIAO, Bin ZHOU. Brief analysis on the collaboration of drugs for rare diseases in China[J]. Chinese Journal of New Drugs, 2023 , 32 (17) : 1707 -1711 .
2023年第32卷第17期
PDF下载
36
16
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-09-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-05-19
基金
作者信息
    1中国医药工业研究总院中国医药工业信息中心,上海 201203
    2天士力生物医药股份有限公司,上海 201203

通讯作者:

周斌,男,研究员,博士研究生导师,主要从事医药产业经济政策与医药政策法规研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236369018882421430
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏